119 related articles for article (PubMed ID: 20307026)
41. Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer.
deVere White RW; Hackman RM; Soares SE; Beckett LA; Li Y; Sun B
Urology; 2004 Feb; 63(2):259-63. PubMed ID: 14972467
[TBL] [Abstract][Full Text] [Related]
42. [The unreasonableness of prostate-cancer screening and the ethical problems pertaining to its investigation].
Bonneux L
Ned Tijdschr Geneeskd; 2005 Apr; 149(18):966-71. PubMed ID: 15903036
[TBL] [Abstract][Full Text] [Related]
43. [Update on screening, diagnosis and treatment of cancer of the prostate].
Chauvet B; Villers A; Davin JL; Nahon S
Bull Cancer; 2002 Jan; 89(1):37-45. PubMed ID: 11847025
[TBL] [Abstract][Full Text] [Related]
44. Cancer overdiagnosis and overtreatment.
Klotz L
Curr Opin Urol; 2012 May; 22(3):203-9. PubMed ID: 22472510
[TBL] [Abstract][Full Text] [Related]
45. Advances in the treatment of metastatic prostate cancer.
Chowdhury S; Kirby R
Practitioner; 2013 Apr; 257(1760):15-8, 2. PubMed ID: 23724747
[TBL] [Abstract][Full Text] [Related]
46. Active surveillance as a treatment option for prostate cancer.
Hegarty J; Bailey DE
Semin Oncol Nurs; 2011 Nov; 27(4):260-6. PubMed ID: 22018405
[TBL] [Abstract][Full Text] [Related]
47. [Treating 'healthy' men who have localised cancer of the prostate].
de Jong IJ
Ned Tijdschr Geneeskd; 2013; 157(42):A6703. PubMed ID: 24128601
[TBL] [Abstract][Full Text] [Related]
48. Prostate Cancer in Elderly Men: Screening, Active Surveillance, and Definitive Therapy.
Roussel B; Ouellet GM; Mohile SG; Dale W
Clin Geriatr Med; 2015 Nov; 31(4):615-29. PubMed ID: 26476120
[TBL] [Abstract][Full Text] [Related]
49. [Active surveillance in prostate cancer].
Valerio M; Vaucher L; Cerantola Y; Berthold D; Herrera F; Jichlinski P
Rev Med Suisse; 2011 Dec; 7(320):2388-91. PubMed ID: 22232867
[TBL] [Abstract][Full Text] [Related]
50. Diagnostic and Therapeutic Strategies for Prostate Cancer.
Nguyen-Nielsen M; Borre M
Semin Nucl Med; 2016 Nov; 46(6):484-490. PubMed ID: 27825428
[TBL] [Abstract][Full Text] [Related]
51. [Overdiagnosis in prostate cancer].
Villeda C; Gomez MO; Sotomayor M
Arch Esp Urol; 2014 Jun; 67(5):388-92. PubMed ID: 24914837
[TBL] [Abstract][Full Text] [Related]
52. Advances in prostate cancer.
Small EJ
Curr Opin Oncol; 1999 May; 11(3):226-35. PubMed ID: 10328599
[TBL] [Abstract][Full Text] [Related]
53. Factors that influence patient enrollment in active surveillance for low-risk prostate cancer.
Gorin MA; Soloway CT; Eldefrawy A; Soloway MS
Urology; 2011 Mar; 77(3):588-91. PubMed ID: 21215429
[TBL] [Abstract][Full Text] [Related]
54. Active surveillance monitoring more stringent in updated NCCN Guidelines for prostate cancer.
J Natl Compr Canc Netw; 2011 May; 9(5):xxxvii-xlii. PubMed ID: 21739727
[No Abstract] [Full Text] [Related]
55. Advances in prostate cancer.
Ryan CJ; Small EJ
Curr Opin Oncol; 2004 May; 16(3):242-6. PubMed ID: 15069320
[TBL] [Abstract][Full Text] [Related]
56. Advances in prostate cancer.
Reeves FA; Corcoran NM
Aust J Gen Pract; 2020 Apr; 49(4):200-205. PubMed ID: 32233346
[TBL] [Abstract][Full Text] [Related]
57. Prostate cancer: review in 2014.
Barry Delongchamps N
Diagn Interv Imaging; 2014; 95(7-8):739-42. PubMed ID: 25052225
[TBL] [Abstract][Full Text] [Related]
58. Cancer of the prostate.
Dearnaley DP
BMJ; 1994 Mar; 308(6931):780-4. PubMed ID: 8142838
[TBL] [Abstract][Full Text] [Related]
59. Should Men Diagnosed With Prostate Cancer Hit the Gym?
Feng TS; Vidal AC; Freedland SJ
Oncology (Williston Park); 2015 Sep; 29(9):689-90, 694. PubMed ID: 26384806
[No Abstract] [Full Text] [Related]
60. An update on prostate cancer research.
Small EJ; Reese DM
Curr Opin Oncol; 2000 May; 12(3):265-72. PubMed ID: 10841200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
